Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients

D Menichelli, F Del Sole, A Di Rocco… - European Heart …, 2021 - academic.oup.com
Aims To analyse the safety and efficacy of direct oral anticoagulants (DOACs) in real-world
studies including atrial fibrillation (AF) patients. Methods and results Systematic review and …

Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis

J Zhang, X Wang, X Liu, TB Larsen, DM Witt… - European Journal of …, 2021 - Springer
Purpose: To systematically review available evidence of indirect comparisons from RCTs
and direct comparisons from observational studies regarding the comparative effectiveness …

The importance of appropriate dosing of nonvitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation

J Beyer-Westendorf, M Fay, W Amara - TH Open, 2021 - thieme-connect.com
Preventing thromboembolic events, while minimizing bleeding risks, remains challenging
when managing patients with atrial fibrillation (AF). Several factors contribute to current …

An emulated target trial analysis based on Medicare data suggested non-inferiority of Dabigatran versus Rivaroxaban

H Mei, J Wang, S Ma - Journal of Clinical Epidemiology, 2021 - Elsevier
Abstract Objectives Rivaroxaban and Dabigatran were the first two non-vitamin K antagonist
oral anticoagulants (NOACs) for preventing stroke among non-valvular Atrial Fibrillation …

Critical appraisal and issues regarding generalisability of comparative effectiveness studies of NOACs in atrial fibrillation and their relation to clinical trial data: a …

EM Bunge, B van Hout, S Haas, G Spentzouris… - BMJ open, 2021 - bmjopen.bmj.com
Objective To critically appraise the published comparative effectiveness studies on non-
vitamin K antagonist oral anticoagulants (NOACs) in non-valvular atrial fibrillation (NVAF) …

Analysis of the introduction in clinical practice of new oral anticoagulants in local health agency bt: Translation of the clinical trial data to a local health care area

G Grimaldi, D Ancona, D Tricarico, P Stella, C Procacci… - Pharmaceutics, 2021 - mdpi.com
The commercial release of the New Oral Anticoagulants (NOACs) has been the most
significant change in anticoagulant therapy in recent years. The work aimed to evaluate the …

Comparison of non‐vitamin K antagonist oral anticoagulants on bleeding and thrombosis

Z Liu, L Ma, H Zhang, G Mu, Q Xie… - Journal of Clinical …, 2021 - Wiley Online Library
What is known and objective Limited data are available for the comparison between different
non‐vitamin K antagonist oral anticoagulants (NOACs) on clinical outcomes. We aimed to …

Clinical Treatment Human Disease Networks and Comparative Effectiveness Research: Analyses of the Medicare Administrative Data

H Mei - 2021 - search.proquest.com
As the nation's largest healthcare payer, the Medicare program generates an unimaginable
vast volume of medical data. With an increasing emphasis on evidence-based care, how to …

[PDF][PDF] NOAC & specifiche popolazioni di pazienti

A Fontanella - 2021 - springerhealthcare.it
Pubblicazione fuori commercio riservata alla Classe Medica. Si ringrazia Boehringer
Ingelheim per il supporto all'iniziativa editoriale. Tutti i diritti sono riservati, compresi quelli di …

[PDF][PDF] EliScholar–A Digital Platform for Scholarly Publishing at Yal e

WS Hill - 2021 - core.ac.uk
Abstract A Constitution Contested: Governors, Assemblies, and Imperial Politics in Jamaica
and New York, 1675-1730 Winston Sinclair Hill 2021 This dissertation focuses on the …